The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Granulomatous Rosacea

Rare variant of rosacea with non-caseating granulomas: yellow-brown papules on face

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Granulomatous Rosacea?

Granulomatous rosacea (GR) was previously known as rosacea-like tuberculid or lupoid rosacea. It accounts for ~10% of rosacea cases. Affects predominantly women (3:1) aged 30-50, with darker skin types (Fitzpatrick IV-VI) more affected. Distinct from classic rosacea by presence of granulomas histopathologically and absence of typical vascular features (telangiectasia, flushing).

Pathogenesis: not fully elucidated; theories include Demodex folliculorum mites, abnormal innate immunity (cathelicidin LL-37 dysregulation), follicular rupture with granulomatous response, and abnormal Th1/Th17 response. Differential diagnosis: sarcoidosis (systemic involvement), cutaneous tuberculosis, lupus miliaris disseminatus faciei (LMDF, considered by some as GR variant), perioral dermatitis, acne vulgaris.

Diagnosis: clinical recognition + skin biopsy showing perifollicular non-caseating granulomas (epithelioid histiocytes, multinucleated giant cells, lymphocytes), special stains (PAS, AFB) to exclude infection. Treatment: tetracyclines (doxycycline, minocycline) primary, isotretinoin for refractory, dapsone, topical metronidazole/azelaic acid/ivermectin.

Symptoms

Firm, yellow-brown to red papules and nodules on cheeks, nose, periorbital, perioral regions
Lesions are usually monomorphic and discrete (not pustular)
Diascopy: apple-jelly color (suggesting granulomatous infiltrate)
Asymmetric distribution possible
Mild erythema (less than classic rosacea)
Absence of typical telangiectasia, flushing (distinguishes from ETR)
May involve eyelids (ocular involvement uncommon)
Heals with hyperpigmentation or scarring (especially darker skin)

Risk Factors

Female gender (3:1 ratio)
Darker skin types (Fitzpatrick IV-VI - higher prevalence)
Age 30-50
Demodex folliculorum infestation (proposed cofactor)
Family history of rosacea or sarcoidosis
Topical/systemic corticosteroid use (steroid-induced rosacea variant)
Cosmetic use, skin barrier dysfunction
Sun exposure, heat, spicy foods (worsen)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent yellow-brown firm papules on face >2 months
  • Failed treatment for presumed acne or perioral dermatitis
  • Granulomatous facial papules in patient with darker skin
  • Persistent papules without comedones or pustules
  • Concerns about sarcoidosis or other granulomatous disease
  • Worsening after topical corticosteroid use
  • Scarring or hyperpigmentation developing

Treatment Methods

01
Doxycycline (40 mg or 100 mg/day) - first-line systemic therapy
02
Minocycline (50-100 mg/day) - alternative tetracycline
03
Isotretinoin (low-dose, 10-20 mg/day) - refractory cases
04
Dapsone (50-100 mg/day) - alternative for refractory
05
Topical metronidazole 0.75-1% - daily
06
Topical azelaic acid 15% gel - twice daily
07
Topical ivermectin 1% - especially with Demodex involvement
08
Avoid topical corticosteroids (worsen)
09
Sunscreen (SPF 30+, broad-spectrum)
10
Trigger avoidance (heat, alcohol, spicy food)
11
Treatment duration 3-6 months minimum
12
Camouflage cosmetics for cosmetic concerns
13
Skin biopsy if diagnosis uncertain (rule out sarcoidosis, TB)
14
Long-term maintenance to prevent recurrence

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.